Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Prepare for a seismic shift in the conversation around medicine and health as PHARMAGEDDON, a provocative new documentary, ...

Sun Pharmaceutical Industries announces a USD 100 million investment to commercialize new speciality products, strengthening ...

South Korean pharmaceutical and biotech companies are on track to exceed 10 trillion won ($7.5 billion) in licensing revenues ...

A final dividend and a number of strategic initiatives were highlighted by Hyderabad-based pharmaceutical company Sigachi ...

FDA approvals for new biosimilars like Starjemza and Hadlima enhance treatment options, addressing urgent needs for ...

CHENNAI: India’s largest drug maker, Sun Pharmaceutical Industries, has completed its acquisition of US-based Checkpoint Therapeutics for approximately $355 mil ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...